Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.

Gumus, Pinar; Budunelı, ZEKİ; Bıyıkoglu, Basak; Aksu, KENAN; Sarac, ZELİHA; Nile, Christopher; Lappin, David; Budunelı, Nurcan

doi:10.1902/jop.2013.120595

Gingival crevicular fluid, serum levels of receptor activator of nuclear factor-κB ligand, osteoprotegerin, and interleukin-17 in patients with rheumatoid arthritis and osteoporosis and with periodontal disease.

Atıf İçin Kopyala

Gumus P., Budunelı E. , Bıyıkoglu B., Aksu K. , Sarac F. , Nile C., ...Daha Fazla

Journal of periodontology, cilt.84, ss.1627-37, 2013 (SCI Expanded İndekslerine Giren Dergi)

Cilt numarası: 84
Basım Tarihi: 2013
Doi Numarası: 10.1902/jop.2013.120595
Dergi Adı: Journal of periodontology
Sayfa Sayıları: ss.1627-37

Özet

Background: This study is performed to evaluate gingival crevicular fluid (GCF) and serum levels of soluble receptor activator of nuclear factor-kappa B ligand (sRANKL), interleukin (IL)-17A, IL-17E, IL-17F, IL-17A/F, and osteoprotegerin (OPG) in women with rheumatoid arthritis (RA), osteoporosis (OPR), and those who are systemically healthy (SH), all with periodontal disease.